These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 35758518)

  • 1. Predicting the loss to follow-up (LTFU) of HIV/AIDS patients in China using a recency-frequency (RF) model.
    Li M; Wang Q
    HIV Med; 2023 Jan; 24(1):82-92. PubMed ID: 35758518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence predictor variables in AIDS patients: an empirical study using the data mining-based RFM model.
    Li M; Wang Q; Shen Y
    AIDS Res Ther; 2021 Jan; 18(1):6. PubMed ID: 33509194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Customer relationship management analysis of outpatients in a Chinese infectious disease hospital using drug-proportion recency-frequency-monetary model.
    Li M; Wang Q; Shen Y; Zhu T
    Int J Med Inform; 2021 Mar; 147():104373. PubMed ID: 33418439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss to follow-up and associated factors of patients in the National AIDS Program in Thailand.
    Teeraananchai S; Kerr SJ; Ruxrungtham K; Avihingsanon A; Chaivooth S; Teeraratkul A; Bhakeecheep S; Ongwandee S; Thanprasertsuk S; Law MG
    Antivir Ther; 2018; 23(6):529-538. PubMed ID: 29583122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline and Process Factors of Anti-Retroviral Therapy That Predict Loss to Follow-up Among People Living with HIV/AIDS in China: A Retrospective Cohort Study.
    Xie J; Gu J; Chen X; Liu C; Zhong H; Du P; Li Q; Lau JTF; Hao C; Li L; Hao Y; Cai W
    AIDS Behav; 2022 Apr; 26(4):1126-1137. PubMed ID: 34698955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of loss to follow up from antiretroviral therapy among adolescents with HIV/AIDS in Tanzania.
    Tesha ED; Kishimba R; Njau P; Revocutus B; Mmbaga E
    PLoS One; 2022; 17(7):e0268825. PubMed ID: 35857796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of loss to follow-up among HIV positive patients receiving antiretroviral therapy in a test and treat setting: A retrospective cohort study in Masaka, Uganda.
    Kiwanuka J; Mukulu Waila J; Muhindo Kahungu M; Kitonsa J; Kiwanuka N
    PLoS One; 2020; 15(4):e0217606. PubMed ID: 32255796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early loss to follow-up of recently diagnosed HIV-infected adults from routine pre-ART care in a rural district hospital in Kenya: a cohort study.
    Hassan AS; Fielding KL; Thuo NM; Nabwera HM; Sanders EJ; Berkley JA
    Trop Med Int Health; 2012 Jan; 17(1):82-93. PubMed ID: 22943164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss to follow-up correction increased mortality estimates in HIV-positive people on antiretroviral therapy in Mozambique.
    Anderegg N; Hector J; Jefferys LF; Burgos-Soto J; Hobbins MA; Ehmer J; Meier L; Maathuis MH; Egger M
    J Clin Epidemiol; 2020 Dec; 128():83-92. PubMed ID: 32828836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a risk prediction model for lost to follow-up among adults on active antiretroviral therapy in Ethiopia: a retrospective follow-up study.
    Fentie DT; Kassa GM; Tiruneh SA; Muche AA
    BMC Infect Dis; 2022 Sep; 22(1):727. PubMed ID: 36071386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Illicit drug use is a significant risk factor for loss to follow up in patients with HIV-1 infection at a large urban HIV clinic in Tokyo.
    Nishijima T; Gatanaga H; Komatsu H; Takano M; Ogane M; Ikeda K; Oka S
    PLoS One; 2013; 8(8):e72310. PubMed ID: 23951307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subdividing ART patients and analyzing the medical burden by modeling of CD4 cell count.
    Min L; Qunwei W
    J Family Med Prim Care; 2023 Feb; 12(2):352-359. PubMed ID: 37091020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss to follow-up before and after initiation of antiretroviral therapy in HIV facilities in Lilongwe, Malawi.
    Tweya H; Oboho IK; Gugsa ST; Phiri S; Rambiki E; Banda R; Mwafilaso J; Munthali C; Gupta S; Bateganya M; Maida A
    PLoS One; 2018; 13(1):e0188488. PubMed ID: 29373574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of three computational modelling methods for the prediction of virological response to combination HIV therapy.
    Wang D; Larder B; Revell A; Montaner J; Harrigan R; De Wolf F; Lange J; Wegner S; Ruiz L; Pérez-Elías MJ; Emery S; Gatell J; D'Arminio Monforte A; Torti C; Zazzi M; Lane C
    Artif Intell Med; 2009 Sep; 47(1):63-74. PubMed ID: 19524413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on the prevalence of loss to follow-up and risk factors among human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) patients in Baoshan city, Yunnan province].
    Huang D; Zheng W; Yang J; Li Y; Hu A; Xu Z
    Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Aug; 48(8):688-92. PubMed ID: 25388464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of loss to follow-up among children in the first and second years of antiretroviral treatment in Johannesburg, South Africa.
    Sengayi M; Dwane N; Marinda E; Sipambo N; Fairlie L; Moultrie H
    Glob Health Action; 2013 Jan; 6():19248. PubMed ID: 23364098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss to follow-up of patients in HIV care in Burundi: A retrospective cohort study.
    Nshimirimana C; Ndayizeye A; Smekens T; Vuylsteke B
    Trop Med Int Health; 2022 Jun; 27(6):574-582. PubMed ID: 35411666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High loss to follow-up of children on antiretroviral treatment in a primary care HIV clinic in Johannesburg, South Africa.
    Chandiwana N; Sawry S; Chersich M; Kachingwe E; Makhathini B; Fairlie L
    Medicine (Baltimore); 2018 Jul; 97(29):e10901. PubMed ID: 30024494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.
    Agolory SG; Auld AF; Odafe S; Shiraishi RW; Dokubo EK; Swaminathan M; Dalhatu I; Onotu D; Abiri O; Debem H; Bashorun A; Ellerbrock TV
    PLoS One; 2017; 12(9):e0183823. PubMed ID: 28863160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss to follow-up in "test and treat era" and its predictors among HIV-positive adults receiving ART in Northwest Ethiopia: Institution-based cohort study.
    Bantie B; Seid A; Kerebeh G; Alebel A; Dessie G
    Front Public Health; 2022; 10():876430. PubMed ID: 36249247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.